Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 54,568 | 52,775 | 65,675 | 57,102 | 59,518 |
| Cost of Goods | 11,857 | 13,218 | 16,836 | 12,495 | 14,918 |
| Gross Profit | 42,711 | 39,557 | 48,839 | 44,607 | 44,600 |
| Operating Expenses | 38,676 | 35,410 | 39,659 | 42,709 | 33,460 |
| Operating Income | 4,892 | 4,365 | 10,016 | 2,393 | 12,058 |
| Interest Expense | 3,325 | 3,312 | 3,279 | 2,947 | 2,702 |
| Other Income | 746 | 495 | -12,049 | 261 | 72 |
| Pre-tax Income | 2,313 | 1,548 | -5,312 | -293 | 9,428 |
| Income Tax | 187 | 147 | 294 | 67 | 57 |
| Net Income Continuous | 2,126 | 1,401 | -5,606 | -360 | 9,371 |
| Net Income | $2,126 | $1,401 | $-5,606 | $-360 | $9,371 |
| EPS Basic Total Ops | 0.05 | 0.03 | -0.12 | -0.01 | 0.21 |
| EPS Basic Continuous Ops | 0.05 | 0.03 | -0.12 | -0.01 | 0.21 |
| EPS Diluted Total Ops | 0.05 | 0.03 | -0.12 | -0.01 | 0.21 |
| EPS Diluted Continuous Ops | 0.05 | 0.03 | -0.12 | -0.01 | 0.21 |
| EBITDA(a) | $7,768 | $7,243 | $12,469 | $4,862 | $14,519 |